Literature DB >> 16364491

The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.

John G McHutchison1, Ralf Bartenschlager, Keyur Patel, Jean-Michel Pawlotsky.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16364491     DOI： 10.1016/j.jhep.2005.12.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  18 in total

1.  Crystal structure of the HCV IRES central domain reveals strategy for start-codon positioning.

Authors:  Katherine E Berry; Shruti Waghray; Stefanie A Mortimer; Yun Bai; Jennifer A Doudna
Journal:  Structure       Date:  2011-10-12       Impact factor: 5.006

Review 2.  Diagnosis and treatment of chronic hepatitis C infection.

Authors:  Keyur Patel; Andrew J Muir; John G McHutchison
Journal:  BMJ       Date:  2006-04-29

3.  Managing chronic hepatitis C in primary-care settings: more than antiviral therapy.

Authors:  Barry Zevin
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

4.  Managing Hepatitis C in Users of Illicit Drugs.

Authors:  Brian R Edlin; Michael R Carden; Stephen J Ferrando
Journal:  Curr Hepat Rep       Date:  2007

Review 5.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

6.  Effect of peginterferon alfa-2a (40KD) on cytochrome P450 isoenzyme activity.

Authors:  Barbara J Brennan; Zhi-Xin Xu; Joseph F Grippo
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 7.  Specific targeted antiviral therapy for hepatitis C.

Authors:  Mark S Sulkowski
Journal:  Curr Gastroenterol Rep       Date:  2007-03

8.  Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection.

Authors:  Shazia Rafique; Muhammad Idrees; Amjad Ali; Kashif Iqbal Sahibzada; Muhammad Iqbal
Journal:  Mol Biol Rep       Date:  2014-02-19       Impact factor: 2.316

Review 9.  Drugs in development for hepatitis C.

Authors:  Rudolf E Stauber; Harald H Kessler
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Treatment of hepatitis C virus infection.

Authors:  Kilian Weigand; Wolfgang Stremmel; Jens Encke
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.